If you can't read this mail, click-here
 
FR
EN
EDITO  
Let's build together

As we move towards a new epidemic peak with the restrictive measures that follow, we must not only continue to do everything to protect residents and teams, but we also have an obligation to prepare the ground for the future.
READ
The « societe a mission »
in 5 questions


Should a company be useful - beyond its customers, its employees, its shareholders - to society as a whole ? The answer was yes for the State when he introduced into law in 2019 the possibility for a company to declare itself a "societe à mission". Let's decipher this ambitious facility together.
  DECRYPTION
READ
VISION  
Becoming “societe a mission” : a new ambition

It is official this March : Colisee is now a "societe a mission". The group has formalized in its statutes its specific mission at the service of the general interest. It is both the culmination of a long-standing CSR process but also a new step to go further.
READ
CSR : the unifying element of better aging in Europe

We often speak of the “Old Continent”. The fact is that “old Europe” has become and will be even more tomorrow the continent where demographic aging will be the most exacerbated. Therefore, making "aging better" a priority of general interest in Europe is more essential than anywhere else.
  EUROPE
READ
Follow us
 
About Colisée
With 16 000 collaborators, COLISEE Group is a leading European player with benchmark expertise in serving and caring for the elderly. Its network of medical facilities and residences with services in France, Belgium, Spain, Italy and China welcomes more than 25 000 residents and patients. Colisée offers also home services. Its majority shareholders are EQT and CDPQ.
  Legal Notices
All contents of the site http://www.groupecolisee.com are protected by copyright. Any complete or partial reproduction is subject to the agreement of the author under article L.122-4 of the Intellectual Property Code. After having obtained this agreement, the reproduction of the pages of this site is authorized on condition of mentioning the source and providing the corresponding links. Any other reproduction or use for commercial purposes of these documents may not take place without the written authorization of the author.